Key Players
Competitive Landscape
AI-enabled digital stethoscope market includes cardiac analysis companies, respiratory monitoring suppliers, clinician-operated hardware manufacturers and audio connectivity providers. Eko Health offers electronic stethoscopes with cardiac analysis software, whereas TytoCare combines lung-sound analysis with remote examination. AEvice Health is engaged in wearable respiratory recording and Thinklabs provides live or transferred digital audio. Some of the key players are focusing on product clearance, recording quality, compatible software and clinical review functions in order to increase market share.
Product development in AI-enabled digital stethoscope market increased across hardware and analysis software during 2026. FDA cleared AiSteth in May and CORE 300 in July, whereas TytoCare received clearance for updated wheeze-detection software in June. In April 2026, Health Canada also published lifecycle guidance for machine-learning-enabled medical devices. These developments are leading manufacturers to focus on compatible hardware, clinical validation and software update controls. Increasing number of cleared devices and controlled AI updates is expected to intensify competition over the forecast period.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| July 2026: FDA cleared Eko Health, Inc.’s CORE 300 Digital Stethoscope.[30] | Increasing demand for updated clinician-operated hardware. | Electronic stethoscopes are increasingly adding connected functions. | New hardware can increase application of compatible cardiac software. |
| May 2026: FDA cleared Ai Health Highway’s AiSteth electronic stethoscope.[31] | Hospitals require additional cleared sound acquisition devices. | New entrants are expanding the handheld digital stethoscope segment. | Distributor training can support correct product use and configuration. |
| April 2026: Health Canada issued machine-learning-enabled medical-device guidance.[4] | Machine-learning software requires lifecycle evidence. | Change controls and representative data are gaining importance. | Canadian validation and post-market plans can support product approval. |
Eko Health, Inc. and HD Medical, Inc. focus on clinician-operated cardiac examination, whereas TytoCare Ltd. and AEvice Health Pte. Ltd. extend sound collection into remote or longer respiratory monitoring. Solventum Corporation, Thinklabs Medical LLC and M3DICINE Pty Ltd provide hardware or connectivity routes. StethoMe sp. z o.o., Sanolla Ltd. and Sonavi Labs, Inc. offers respiratory analysis, recording or review functions. Product development and expansion of connected examination are expected to intensify competition.
Source: Future Market Insights, AI-Enabled Digital Stethoscope Market Report, 2026-2036.
The profiled companies offers cardiac screening, respiratory analysis, connected sound collection and remote clinical review under different intended uses. Expansion of these functions is expected to support wider application of AI-enabled digital stethoscopes.
Who leads the AI-enabled digital stethoscope market?
One verified market-share leader is not established from the available public information. Eko Health has wider documented cardiac analysis, whereas TytoCare offers separate respiratory algorithms with remote examination. Different product functions are resulting in competition across cardiac and respiratory applications.
Which companies have documented cardiac or respiratory analysis?
Eko Health offers FDA-cleared cardiac sound and ECG-dependent analysis through EFAST. TytoCare has separate FDA records for wheeze and rhonchi detection, whereas StethoMe describes several respiratory sound classes. Increasing availability of disease-specific sound analysis is expected to widen the application of digital stethoscopes.
Which companies support remote examination or audio transfer?
TytoCare supports guided physical examination using compatible stethoscope recordings, whereas AEvice Health provides wearable respiratory observation. Thinklabs Medical is focused on live or transferred audio for telemedicine systems. These remote functions are expected to support digital stethoscope use outside hospitals and clinics.
What should buyers evaluate before approving a supplier?
Hospitals and telehealth providers require the intended use, compatible hardware, eligible algorithm and trained user before adopting an AI-enabled digital stethoscope. Availability of clear data access and clinical review is also important as abnormal results require further assessment. Products that can fit into existing examination and clinical record systems are expected to witness higher adoption.
How is competition expected to change through 2036?
Competition through 2036 is expected to center on clinician-operated stethoscopes with multi-lead rhythm interpretation, integrated telehealth workflows with validated respiratory sound analysis, and established reimbursement coverage. Suppliers demonstrating end-to-end device security, verified diagnostic sensitivity, and seamless electronic health record connectivity will maintain the strongest commercial positioning across regional healthcare systems.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Eko Health, Inc. | Cardiac analysis and clinician-operated digital stethoscopes. | July 2026 FDA clearance for CORE 300 Digital Stethoscope.[30] |
| Solventum Corporation | Digital auscultation hardware through the Littmann CORE offer. | Current product documentation separates stethoscope hardware from optional connected software.[13] |
| TytoCare Ltd. | Remote examination with lung-sound decision support. | June 2026 FDA clearance for wheeze detection with a PCCP.[7] |
| Thinklabs Medical LLC | Electronic stethoscope audio for telemedicine connectivity. | Current documentation supports live or transferred digital audio workflows.[14] |
| HD Medical, Inc. | Cardiac acoustic and ECG-supported clinical examination. | FDA documentation defines clinician-operated HD Steth use.[15] |
| AEvice Health Pte. Ltd. | Wearable respiratory recording for clinician review. | May 2025 FDA clearance for AeviceMD monitoring in patients aged three years and older.[8] |
| StethoMe sp. z o.o. | Patient-directed respiratory sound collection and classification. | Company documentation lists wheeze, rhonchi, and crackle analysis.[16] |
| Sanolla Ltd. | Electronic auscultation with on-device support. | September 2025 direct physician sales launch for VoqX.[19] |
| Sonavi Labs, Inc. | Digital sound capture and cloud-supported review. | Current FeelixPro documentation describes connected recording and review.[17] |
| M3DICINE Pty Ltd | Historical connected cardiac and respiratory auscultation system. | Company documentation states Stethee Pro is not currently commercially available.[20] |
Research Methodology
The competitive assessment includes companies engaged in AI-enabled auscultation hardware, cardiac analysis, respiratory monitoring and clinical audio connectivity. Information is collected from regulatory records, official company announcements and product documents. Companies are assessed on the basis of available function, intended use, current product activity and geographic availability. The ratings describe publicly documented capability and do not represent company revenue or global market share.
